✦ LIBER ✦
Antiviral activity and safety of aplaviroc, a CCR5 antagonist, in combination with lopinavir/ritonavir in HIV-infected, therapy-naïve patients: results of the EPIC study (CCR100136)
✍ Scribed by P Yeni; A LaMarca; D Berger; P Cimoch; A Lazzarin; P Salvato; FM Smaill; E Teofilo; SJ Madison; WG Nichols; KK Adkison; T Bonny; J Millard; D McCarty; the EPIC (CCR100136) study team
- Book ID
- 111063563
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 233 KB
- Volume
- 10
- Category
- Article
- ISSN
- 1464-2662
No coin nor oath required. For personal study only.